1 / 13

New Tools of Toxicology and Exposure Science: Opportunities for Informing Low-Dose Evaluations

New Tools of Toxicology and Exposure Science: Opportunities for Informing Low-Dose Evaluations. James Bus, PhD, DABT, ATS The Dow Chemical Company “Beyond Science and Decisions: From Problem Formulation to Dose Response” Workshop I, March 16-18, 2010 Austin, Texas.

jacob-byers
Download Presentation

New Tools of Toxicology and Exposure Science: Opportunities for Informing Low-Dose Evaluations

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. New Tools of Toxicology and Exposure Science: Opportunities for Informing Low-Dose Evaluations James Bus, PhD, DABT, ATS The Dow Chemical Company “Beyond Science and Decisions: From Problem Formulation to Dose Response” Workshop I, March 16-18, 2010 Austin, Texas

  2. The Paradigm Shift: Low-dose linear response default assumption for cancer and non-cancer endpoints • Did Silver Book seriously considered critical alternative, i.e., all responses exhibit practical thresholds (non-linear behaviors)? • Evidence of thresholds (non-linear behavior) for all responses: • Radiation and chemical hormesis • DNA-reactive substances – genotoxicity assays • Whole animal cancer and non-cancer bioassays

  3. Assumption of Linearity: The “natural chemicals” conundrum • Tens’s of thousands of natural chemicals in everyday environment • Many present in significant doses in “healthy foods” • Exhibit full range of toxicologic properties associated with anthropogenic chemicals, including genotoxic activity • Silver Book default assumption of linear low-dose toxicity responses further magnifies natural chemical conundrum, i.e., otherwise “healthy” foods are judged to be even “unhealthier” • Future risk assessment paradigm must be able to differentiate healthy food from true chemical risks >>> What can new tools of toxicology and exposure science reveal?

  4. Value of new tools of toxicology: Dose-response Naciff et.al., Tox.Sci. 2005

  5. Genetic susceptibility Susceptibility: Dose response implications PON1 KO? Wild-type Response Dose

  6. * * 20 MNU MMS 15 * Reticulocyte-MN (‰ ave) 10 * * 5 * 0 0 0.01 0.1 0.5 1 5 10 25 50 Dose group (mkd, 4d) Nonlinear Dose Response for Micronuclei (MN) in Reticulocytesas Measured by Flow Cytometry

  7. 125 100 75 Genes Significantly Changed vs. Control (#) 50 25 0 0.5 5 50 MMS (mkd, 4d) Genes Significantly Changed in Liver vs. Control as Measured by Microarray ↝ Agilent complete rat genome (41,121) ↝ GeneSpring prefilter (21,205) ↝ ANOVA p<0.001 (126)↝ Tukey’s post-hoc p<0.05 (20 and 121)

  8. Mega-Fish Study: Non-linear Response to Genotoxic Carcinogen Dibenzo[a,l] pyrene Bailey et.al., Chem.Res.Toxicol. 22: 1264-1276 (2009)

  9. Value of new tools of toxicology: Modes of Action • Rapid identification of “alternative” modes of action • Liver tumors: PPARα vs CYP P450 enzyme induction • Improved animal models, e.g., humanized mice • Identify and test potential animal-model-specific responses • Test hypothesized “common” and/or “cumulative” modes of action • AhR-mediated toxicity • Assess question of “how to add” risks of complex mixtures

  10. Exposure-dosimetry relationships: Implications for future risk assessment • Advancements in analytical and modeling technologies rapidly improving both animal dosimetry and human exposure evaluations (biomonitoring) • Refinements to “Margin of Exposure” approaches • “Biomonitoring Equivalents” approach (Hays et.al., Reg.Toxicol.Pharmacol 47: 96-109, 2007) • Internal dosimetry for short half-life compounds • Steady-state concentrations under conditions of toxicity test • Peak and/or steady-state AUCs in human exposures

  11. Linking Animal Toxicity Tests to Human Exposure From: Hays et.al., Reg.Toxicol.Pharmacol 47: 96-109, 2007

  12. Linking Animal Test Doses to Human Exposure Saghir et.al., TAAP 211: 245, 2006

  13. Summary • New tools of toxicology offer unprecedented opportunities to better characterize the shape of the dose response under dose-exposure conditions relevant to real world exposure • Emerging data provides biological basis for existence of toxicological thresholds (non-linearities), even for genotoxic substances • Human exposure advances and information can be integrated into dose-response considerations of toxicity tests • Opportunities to improve Margin of Exposure risk approaches • Objective: Differentiate “healthy” from “harmful”

More Related